UBS Maintains a 'Sell' on ConocoPhillips (COP); Update From Investor Meeting
Get Alerts COP Hot Sheet
Price: $125.98 -0.63%
Rating Summary:
27 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
27 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
UBS maintains a 'Sell' on ConocoPhillips (NYSE: COP) price target raised $2 to $64.
Analyst, William A. Featherston, said, "COP reiterated its key targets: 1) 2012 production of ~1.55 MMBoed; 2) 3-5% production growth per annum through 2016; 3) 3-5% per annum improvement in margins; 4) $15 billion in capex/annum through 2016; and 5) average F&D costs of $20/Boe."
"Are these targets achievable? In order for reserve growth to broadly match production growth (~3% per annum), we estimate capex would have to increase by $3-4 billion in 2015-16 or the company would have to materially outperform its $20/Boe F&D target." (UBS raises FY12 EPS estimate from $8.55 to $8.62, but lowers FY13 from $8.77 to $8.36)
For an analyst ratings summary and ratings history on ConocoPhillips click here. For more ratings news on ConocoPhillips click here.
Shares of ConocoPhillips closed at $73.83 yesterday.
Analyst, William A. Featherston, said, "COP reiterated its key targets: 1) 2012 production of ~1.55 MMBoed; 2) 3-5% production growth per annum through 2016; 3) 3-5% per annum improvement in margins; 4) $15 billion in capex/annum through 2016; and 5) average F&D costs of $20/Boe."
"Are these targets achievable? In order for reserve growth to broadly match production growth (~3% per annum), we estimate capex would have to increase by $3-4 billion in 2015-16 or the company would have to materially outperform its $20/Boe F&D target." (UBS raises FY12 EPS estimate from $8.55 to $8.62, but lowers FY13 from $8.77 to $8.36)
For an analyst ratings summary and ratings history on ConocoPhillips click here. For more ratings news on ConocoPhillips click here.
Shares of ConocoPhillips closed at $73.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cullinan Oncology Inc. (CGEM) PT Raised to $27 at UBS
- Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
- Broadridge Financial (BR) PT Raised to $180 at UBS, Neutral Rating Maintained
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share